Inventor · disambiguated record
Leda Mannent
Also filed as: MANNENT LEDA
4 granted patents·7 pending applications·65 citations·filing 2014–2025
78Inventor score
Top patents by PatentIndex Score
11 records- 0194US10066017B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2015·Granted Sep 4, 2018·25 cites·33 claims
- 0293US10059771B2Methods for treating nasal polyposis by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2014·Granted Aug 28, 2018·26 cites·57 claims
- 0391US11053309B2Methods for treating active eosinophilic esophagitisREGENERON PHARMA·Filed 2018·Granted Jul 6, 2021·12 cites·22 claims
- 0484US11214621B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Granted Jan 4, 2022·2 cites·39 claims
- 0569US2022204631A1Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 0663US2021363237A1Methods for treating active eosinophilic esophagitisREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0759US2024360232A1Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 0857US2023146317A1Methods for treating chronic spontaneous urticaria by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 0950US2019040146A1Methods for treating nasal polyposis by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Application pending·0 cites
- 1047US2025388685A1Methods for treating chronic rhinosinusitis without nasal polyps by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 1146US2025154267A2Methods for treating eosinophilic esophagitis by administering an il-4r inhibitorREGENERON PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leda Mannent files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →